Tiziana Life Sciences Announces Planned Spin Out of StemPrintER into a New Publicly Listed Company, Accustem Sciences

    NEXT STORY
    SpringWorks Therapeutics Announces Collaboration with Children’s Oncology Group to Conduct a Phase 2 Clinical Trial of Nirogacestat in Pediatric Patients with Desmoid Tumors and Reports Publication of Nirogacestat Case Series in Pediatric/Young Adult Desmoid Tumor Patients
    PREV STORY
    mHealth Apps Market size is projected to reach USD 57.57 billion with 21.1% CAGR till 2026; Driven by Increasing Investment in the Development of Newer Products, says Fortune Business Insights™
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cancer Genetics to Present Insights to Advance Precision Medicine in Non-Small Cell Lung Cancer (NSCLC) at AMP Annual Meeting 2017

    The two presentations at AMP highlight the role of next-generation sequencing in lung cancer ...

    author_avatar
    NASDAQ Market News

    ADMA Biologics Receives Unique Permanent J-Code for ASCENIV™

    author_avatar
    NASDAQ Market News

    Ziopharm Oncology Reports Third Quarter 2019 Financial Results

    author_avatar
    NASDAQ Market News